- Trials with a EudraCT protocol (174)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
174 result(s) found for: ST-segment Elevation Myocardial Infarction.
Displaying page 6 of 9.
EudraCT Number: 2011-003320-12 | Sponsor Protocol Number: STH16207 | Start Date*: 2011-12-06 | |||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Study of the effect of morphine on prasugrel absorption in patients with prior history of ST elevation myocardial infarction | |||||||||||||
Medical condition: Complete occlusion of a major coronary artery branch causing ST elevation on electrocardiogram. Adjunctive pharmacological therapy (including prasugrel) is given at the time of PPCI. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024616-33 | Sponsor Protocol Number: TRO40303CLEQ1491-1 | Start Date*: 2011-08-04 | |||||||||||
Sponsor Name:TROPHOS SA | |||||||||||||
Full Title: Phase II, multicenter, randomized, double-blind, placebo controlled study to assess safety and efficacy of TRO40303 for reduction of reperfusion injury in patients undergoing Percutaneous Coronary ... | |||||||||||||
Medical condition: Treatment for cardiac reperfusion injury in patients undergoing PCI( Percutaneous coronary intervention) to treat an AMI (Acute Myocardial Infarction) and to assess safety as well as the ability of... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000631-40 | Sponsor Protocol Number: T3inj-01 | Start Date*: 2016-04-04 | |||||||||||
Sponsor Name:Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | |||||||||||||
Full Title: Triiodothyronine for repair of left ventricular dysfunction and Remodeling in STEMI Patients | |||||||||||||
Medical condition: Patients with anterior or anterolateral STEMI subjected to primary PCI. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000573-80 | Sponsor Protocol Number: APHP201075 | Start Date*: 2021-05-10 |
Sponsor Name:APHP DRCI | ||
Full Title: Acute Myocardial infarction Upbound to percutaneous coronary intervention, immediately (STEMI) or in the Next three Days (NSTEMI), and randomized to Subcutaneous Evolocumab or Normal strategies to ... | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) DE (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005273-23 | Sponsor Protocol Number: 923 | Start Date*: 2012-01-30 | |||||||||||
Sponsor Name:Liverpool Heart and Chest Hospital | |||||||||||||
Full Title: HEAT-PPCI - How Effective are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention - A randomised controlled trial to compare unfractionated heparin versus bivalirudin in the trea... | |||||||||||||
Medical condition: ST elevation myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012852-26 | Sponsor Protocol Number: EFC11319 | Start Date*: 2010-09-06 | |||||||||||
Sponsor Name:sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: Estudio multicéntrico doble ciego, aleatorizado, controlado con placebo y de grupos paralelos, para evaluar los eventos cardiovasculares durante el tratamiento con lixisenatide en pacientes con dia... | |||||||||||||
Medical condition: Diabetes tipo II ___________________ Type II Diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) PT (Completed) GB (Completed) LT (Completed) EE (Completed) DK (Completed) LV (Completed) IT (Completed) NL (Completed) SE (Completed) FR (Completed) FI (Completed) BG (Completed) BE (Completed) NO (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005130-15 | Sponsor Protocol Number: 2019/ABM/01/00009 | Start Date*: 2021-09-30 | |||||||||||
Sponsor Name:Nicolaus Copernicus University in Torun | |||||||||||||
Full Title: Evaluation of safety and efficacy of two ticagrelor-based de-escalation antiplatelet strategies in acute coronary syndrome: the randomized, multicentre, double-blind ELECTRA RCT study. | |||||||||||||
Medical condition: Acute Coronary Syndrom (ACS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002747-16 | Sponsor Protocol Number: AR1108888 | Start Date*: 2008-10-27 | |||||||||||
Sponsor Name:GlaxoSmithKline R & D | |||||||||||||
Full Title: FondaparinUx Trial with UFH during Revascularization in Acute Coronary Syndromes (FUTURA) A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high... | |||||||||||||
Medical condition: Treatment of unstable angina/non-ST elevation myocardial infarction (UA/NSTEMI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) ES (Completed) GB (Completed) FR (Completed) NL (Completed) IT (Completed) CZ (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000047-41 | Sponsor Protocol Number: FDY-5301-201 | Start Date*: 2017-07-06 | |||||||||||
Sponsor Name:Faraday Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2A, Randomized, Double-Blind, Placebo- Controlled, Multi-Center Study of Intravenous FDY-5301 in Acute Myocardial Infarction | |||||||||||||
Medical condition: Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004082-25 | Sponsor Protocol Number: D5130C00137 | Start Date*: 2015-03-27 | |||||||||||
Sponsor Name:Hellenic Cardiovascular Research Society | |||||||||||||
Full Title: A multicenter, prospective, randomized, open label, blinded endpoint, active-comparator trial to assess the MIcrovascular integrity and left ventricular function Recovery after clopidogrel or Ticag... | |||||||||||||
Medical condition: Patients with Myocardial Infarction with ST-segment elevation (STEMI) undergoing thrombolysis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004501-14 | Sponsor Protocol Number: EDC-3135 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ZOLL, Inc. | |||||||||||||
Full Title: COOL-AMI EU PIVOTAL TRIAL: A MULTICENTER, PROSPECTIVE, RANDOMIZED- CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFECTIVENESS OF COOLING AS AN ADJUNCTIVE THERAPY TO PERCUTANEOUS INTERVENTION INP A TIE... | |||||||||||||
Medical condition: Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000721-77 | Sponsor Protocol Number: NITRITE/AMI/4.1 | Start Date*: 2011-12-13 | |||||||||||
Sponsor Name:Barts Health NHS Trust | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled trial assessing the safety and efficacy of intracoronary nitrite infusion during acute myocardial infarction | |||||||||||||
Medical condition: Acute myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016812-18 | Sponsor Protocol Number: AN-CVD2233 | Start Date*: 2011-02-10 | |||||||||||
Sponsor Name:Anthera Pharmaceuticals, Inc. | |||||||||||||
Full Title: Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes | |||||||||||||
Medical condition: Treatment of patients with Acute Coronary Syndromes (ACS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Completed) HU (Prematurely Ended) IT (Prematurely Ended) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000497-38 | Sponsor Protocol Number: VERDI | Start Date*: 2012-07-18 |
Sponsor Name:Fundación FISEVI | ||
Full Title: VERDI Study (VERifynow in Diabetes non-responsiveness: a study on switching from Clopidogrel to Prasugrel). A randomized, mono-center study comparing the treatment plan of a loading dose of prasugr... | ||
Medical condition: Type 2 diabetic patients revascularized with a stent, who have an acute coronary syndrome without persistent ST segment elevation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001682-17 | Sponsor Protocol Number: DRI5228 | Start Date*: 2005-01-14 | |||||||||||
Sponsor Name:Sanofi-Synthelabo-Recherche | |||||||||||||
Full Title: A Randomized Dose Ranging Study of Hexadecasaccharide including Active Control, in Patients with Unstable Angina or Non-ST-segment Elevation Myocardial Infarction Scheduled to Undergo Percutaneous ... | |||||||||||||
Medical condition: Coronary desease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000480-27 | Sponsor Protocol Number: UCC-IGF-001 | Start Date*: 2011-06-03 | |||||||||||
Sponsor Name:University College Cork | |||||||||||||
Full Title: A Randomised Trial Evaluating the Safety and Efficacy of a Single Low Dose of Intracoronary Insulin-like Growth Factor-1 Following Percutaneous Coronary Intervention for ST-Elevation Acute Myocardi... | |||||||||||||
Medical condition: ST Elevation Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001277-14 | Sponsor Protocol Number: P01910 | Start Date*: 2016-02-19 | ||||||||||||||||
Sponsor Name:Royal Papworth Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: A Randomised Mechanistic Study Comparing the Effects of Different Anti-platelet Combinations (Ticagrelor vs. Placebo/ Clopidogrel) with Aspirin in Patients presenting with STEMI Treated with Primar... | ||||||||||||||||||
Medical condition: Patients with ST segment elevation myocardial infarction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-014343-36 | Sponsor Protocol Number: GE IDE NO. I01209 | Start Date*: 2009-09-09 | |||||||||||
Sponsor Name:Deutsches Herzzentrum | |||||||||||||
Full Title: RANDOMIZED TRIAL OF PRASUGREL PLUS BIVALIRUDIN VERSUS CLOPIDOGREL PLUS HEPARIN IN PATIENTS WITH ACUTE STEMI BAVARIAN REPERFUSION ALTERNATIVES EVALUATION [BRAVE-4] TRIAL | |||||||||||||
Medical condition: Acute myocardial infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004282-41 | Sponsor Protocol Number: CEL-02 | Start Date*: 2020-02-21 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:CeleCor Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||||||
Full Title: A Phase-2 open label study to assess the pharmacodynamic and pharmacokinetic properties of a single subcutaneous injection of RUC-4 in patients with ST-elevation myocardial infarction presenting to... | ||||||||||||||||||||||||||||||||||||||
Medical condition: Patients with STEMI, presenting with persistent chest pain (>30 min) and ≥ 1 mm ST-segment elevation in two adjacent electrocardiograph leads, with > 6 mm cumulative ST-segment deviation, in whom ... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001704-37 | Sponsor Protocol Number: CSPP100A2340 | Start Date*: 2006-11-03 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A 36 week, multicenter, randomized, double-blind, placebo- controlled, parallel-group, pilot study to evaluate the efficacy and safety of aliskiren on the prevention of left ventricular remodeling ... | ||
Medical condition: Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) DK (Completed) DE (Completed) SE (Completed) BE (Completed) CZ (Completed) HU (Completed) GB (Completed) SK (Completed) IT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
